Search research articles
Contact Us
Filters
Showing results (461-470 of 596) with videos related to
Page
of 60
Sort By:
Frontiers in Oncology
|
August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
Corey J Langer, Edward S Kim, Eric C Anderson, et al.
Operative Neurosurgery (Hagerstown, Md.)
|
March 20, 2018
Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma
Julia R Schneider, Deborah R Shatzkes, Stephen C Scharf, et al.
Molecular & Cellular Proteomics : MCP
|
July 22, 2009
A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme
Yukihito Kabuyama, Elizabeth S Litman, Paul D Templeton, et al.
JCO Precision Oncology
|
July 15, 2026
EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer
Willdragon Wang, Dylan G Scholes, Alex C Watts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2008
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer
Corey J Langer, Kenneth J O'Byrne, Mark A Socinski, et al.
Journal of Fungi (Basel, Switzerland)
|
August 26, 2021
Highly Clonal Structure and Abundance of One Haplotype Characterise the <i>Diplodia sapinea</i> Populations in Europe and Western Asia
Kalev Adamson, Marili Laas, Kathrin Blumenstein, et al.
JTO Clinical and Research Reports
|
April 21, 2025
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
Margaret Stalker, Suzanne L Walker, Emily Lebow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study
Stephen Leong, Roger B Cohen, Daniel L Gustafson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Page
of 60
Search research articles
Search
Showing results (461-470 of 596) with videos related to
Sort By:
Page
of 60
Frontiers in Oncology
|
August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
Corey J Langer, Edward S Kim, Eric C Anderson, et al.
Operative Neurosurgery (Hagerstown, Md.)
|
March 20, 2018
Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma
Julia R Schneider, Deborah R Shatzkes, Stephen C Scharf, et al.
Molecular & Cellular Proteomics : MCP
|
July 22, 2009
A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme
Yukihito Kabuyama, Elizabeth S Litman, Paul D Templeton, et al.
JCO Precision Oncology
|
July 15, 2026
EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer
Willdragon Wang, Dylan G Scholes, Alex C Watts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2008
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer
Corey J Langer, Kenneth J O'Byrne, Mark A Socinski, et al.
Journal of Fungi (Basel, Switzerland)
|
August 26, 2021
Highly Clonal Structure and Abundance of One Haplotype Characterise the <i>Diplodia sapinea</i> Populations in Europe and Western Asia
Kalev Adamson, Marili Laas, Kathrin Blumenstein, et al.
JTO Clinical and Research Reports
|
April 21, 2025
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
Margaret Stalker, Suzanne L Walker, Emily Lebow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study
Stephen Leong, Roger B Cohen, Daniel L Gustafson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Page
of 60